MK-0457, a novel multikinase inhibitor, has activity in refractory AML, including transformed JAK2 positive myeloproliferative disease (MPD), and in Philadelphia-positive ALL.
Conference Paper
Full Text
Duke Authors
Cited Authors
- Giles, F; Freedman, SJ; Xiao, A; Borthakur, G; Garcia-Manero, G; Wierda, W; Kornblau, SM; O'Brien, S; Bergstrom, DA; Rizzieri, DA
Published Date
- November 16, 2006
Published In
Volume / Issue
- 108 / 11
Start / End Page
- 556A - 557A
Published By
Pages
- 2
Electronic International Standard Serial Number (EISSN)
- 1528-0020
International Standard Serial Number (ISSN)
- 0006-4971
Conference Name
- 48th Annual Meeting of the American-Society-of-Hematology
Conference Location
- Orlando, FL
Conference Start Date
- December 9, 2006
Conference End Date
- December 12, 2006